• In January 2026, CS Diagnostics Corp. announced that it had chosen DHL, part of Deutsche Post, as its global logistics partner to handle bulk and institutional shipments for the worldwide rollout of its MEDUSA SDP healthcare product across diversified B2B and B2C channels.

• This arrangement underscores DHL’s role in supporting complex, multi-channel healthcare logistics, linking hospitals, retailers, online marketplaces, and direct-to-consumer fulfillment across the UAE and Germany.

• Next, we will examine how DHL’s role in MEDUSA SDP’s healthcare distribution network may influence Deutsche Post’s broader investment narrative.

Outshine the giants: these 23 early-stage AI stocks could fund your retirement.

For Deutsche Post, the big picture an investor needs to believe in is a steadier, cash-generating logistics group that can translate its global network into resilient earnings, even when volume growth is modest. The recent MEDUSA SDP mandate with CS Diagnostics fits that story, but it is unlikely to change the near term catalysts on its own; the more important drivers still look like execution on cost control, capital returns through the enlarged €6,000 million buyback, and the company’s ability to sustain margins after its DAX inclusion and recent share price strength. Where the CS Diagnostics deal does matter is in reinforcing DHL’s positioning in higher value healthcare logistics, which slightly tilts the risk balance away from pure volume sensitivity and toward continued success in winning complex contracts.

But there is one operational risk in particular that current shareholders should not ignore. Despite retreating, Deutsche Post’s shares might still be trading above their fair value and there could be some more downside. Discover how much.

The Simply Wall St Community’s 11 fair value views range widely, from €34 to almost €96, showing just how far apart private investors can be. Set that against the current focus on margin resilience and debt levels, and you can see why it pays to weigh several viewpoints before deciding what Deutsche Post’s recent contracts really mean for its longer term performance.

Explore 11 other fair value estimates on Deutsche Post – why the stock might be worth 26% less than the current price!

Disagree with this assessment? Create your own narrative in under 3 minutes – extraordinary investment returns rarely come from following the herd.

• A great starting point for your Deutsche Post research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.

• Our free Deutsche Post research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate Deutsche Post’s overall financial health at a glance.